[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Approvals - June 2005

  ANDA Number Generic Drug Name Applicant Approval Date
1 40-633 BETHANECHOL CHLORIDE TABLETS USP, 5 MG   UPSHER-SMITH LABORATORIES, INC. 6/1/2005 
2 40-634 BETHANECHOL CHLORIDE TABLETS USP, 10 MG   UPSHER-SMITH LABORATORIES, INC. 6/1/2005 
3 40-635 BETHANECHOL CHLORIDE TABLETS USP, 25 MG   UPSHER-SMITH LABORATORIES, INC. 6/1/2005 
4 40-636 BETHANECHOL CHLORIDE TABLETS USP, 50 MG   UPSHER-SMITH LABORATORIES, INC. 6/1/2005 
5 76-827 VINORELBINE TARTRATE INJECTION, 10 MG (BASE)/ML; PACKAGED IN 10 MG (BASE)/1 ML AND 50 MG (BASE)/5 ML SINGLE-USE VIALS   MAYNE PHARMA (USA), INC. 6/2/2005 
6 40-611 PREDNISONE TABLETS USP, 1 MG   TRIGEN LABORATORIES, INC. 6/6/2005 
7 40-576 CARISOPRODOL TABLETS USP, 350 MG   NEIL LABORATORIES, INC. 6/7/2005 
8 77-026 ACYCLOVIR ORAL SUSPENSION USP, 200 MG/5 ML   HI-TECH PHARMACAL CO., INC. 6/7/2005 
9 76-643 CARBIDOPA AND LEVODOPA TABLETS FOR ORAL SUSPENSION 10 MG/100 MG, 25 MG/100 MG, AND 25 MG/250 MG   RANBAXY LABORATORIES LIMITED 6/10/2005 
10 40-514 FOLIC ACID TABLETS USP, 1 MG   TRIGEN LABORATORIES, INC. 6/14/2005 
11 77-096 CARBOPLATIN INJECTION 10 MG/ML; PACKAGED IN 50 MG/5 ML, 150 MG/15 ML, AND 450 MG/45 ML MULTIPLE-DOSE VIALS   SPECTRUM PHARMACEUTICALS, INC. 6/14/2005 
12 77-109 HALOBETASOL PROPIONATE OINTMENT 0.05%   ALPHARMA USPD INC. 6/14/2005 
13 77-145 FLUTICASONE PROPIONATE OINTMENT 0.005%   TARO PHARMACEUTICAL INDUSTRIES, LTD. 6/14/2005 
14 76-426 CIPROFLOXACIN TABLETS USP, 100 MG, 250 MG, 500 MG, AND 750 MG   PLIVA, INC. 6/15/2005 
15 76-516 CLOTRIMAZOLE & BETAMETHASONE DIPROPIONATE LOTION USP, 1%/0.05%(BASE)   ALTANA INC. 6/16/2005 
16 76-752 LEVOTHYROXINE SODIUM TABLETS USP, 0.025 MG, 0.05 MG, 0.075 MG, 0.088 MG, 0.1 MG, 0.112 MG, 0.125 MG, 0.15 MG, 0.175 MG, 0.2 MG, AND 0.3 MG   GENPHARM INC. 6/16/2005 
17 76-469 CROMOLYN SODIUM INHALATION SOLUTION USP, 10 MG/ML; PACKAGED IN 20 MG/2 ML SINGLE- DOSE AMPULES   BREATH LIMITED 6/17/2005 
18 77-349 IBUPROFEN TABLETS USP, (OTC), 200 MG ORANGE-COATED, ROUND & CAPSULE-SHAPED   PERRIGO R&D COMPANY 6/21/2005 
19 76-463 HALOPERIDOL DECANOATE INJECTION 50 MG (BASE)/ML AND 100 MG (BASE)/ML   SABEX 2002 INC. 6/24/2005 
20 65-148 NYSTATIN ORAL SUSPENSION USP, 100,000 UNITS/ML   VINTAGE PHARMACEUTICALS, LLC 6/28/2005 
21 65-248 CEPHALEXIN CAPSULES USP, 250 MG AND 500 MG   ORCHID HEALTHCARE 6/28/2005 
22 76-716 GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLETS 1.25 MG/250 MG, 2.5 MG/500 MG, AND 5 MG/500 MG   PUREPAC PHARMACEUTICAL CO. 6/28/2005 
23 76-901 MIRTAZAPINE ORALLY DISINTEGRATING TABLETS 15 MG, 30 MG, AND 45 MG   TEVA PHARMACEUTICALS USA 6/28/2005 
24 77-196 PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS USP, 100 MG/500 MG   ANDRX PHARMACEUTICALS, LLC 6/28/2005 
25 77-211 METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS 750 MG   RANBAXY LABORATORIES LIMITED 6/29/2005 
26 76-537 GABAPENTIN CAPSULES 100 MG, 300 MG, AND 400 MG   MUTUAL PHARMACEUTICAL COMPANY, INC. 6/30/2005 
27 77-034 CITALOPRAM HYDROBROMIDE TABLETS 10 MG (BASE), 20 MG (BASE), AND 40 MG (BASE)   COBALT PHARMACEUTICALS, INC. 6/30/2005 

Back to Top      Back to Approvals

Date created: July 7, 2005

horizonal rule